Literature DB >> 7518319

Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year.

H A Doll1, N A Black, K McPherson.   

Abstract

OBJECTIVE: To investigate which patient and health service factors are predictive of outcome following transurethral resection for benign prostatic hypertrophy. PATIENTS AND METHODS: A total of 388 men were assessed before and 3, 6 and 12 months following surgery. Twenty-one patient characteristics and 12 health service factors were considered. Successful outcome was assessed in terms of avoidance of adverse effects of the operation (survival, lack of early complications and later problems) and improvement in symptoms, health status (assessed in three ways) and quality of life. An overall assessment based on all eight outcome measures was also used. Relationships between possible predictors and outcome were explored whilst controlling for three potential confounders: age, diagnostic category and co-morbidity. A linear logistic model was employed.
RESULTS: Patients who had severe pre-operative symptoms but who otherwise enjoyed good health gained the most benefit from surgery. Generally speaking, outcome was not associated with any of the 12 health service factors studied.
CONCLUSION: The results support the policy of watchful waiting for mild or moderately symptomatic patients as even if surgery becomes necessary because of a deterioration in the condition, the benefit resulting will be greater. However, any benefits of waiting for surgery would have to be balanced against any increase in urinary tract pathology or co-morbidity that men may suffer whilst waiting, as these will increase the likelihood of an adverse outcome of surgery. The question of whether to wait or not will only finally be resolved by means of a randomized controlled trial comparing transurethral resection of the prostate with watchful waiting.

Entities:  

Mesh:

Year:  1994        PMID: 7518319     DOI: 10.1111/j.1464-410x.1994.tb07554.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  New treatments for benign prostatic hypertrophy.

Authors:  M McKee; N Black; D Hunter; C Sanderson
Journal:  BMJ       Date:  1994-11-05

2.  Iatrogenic damage to male reproductive function.

Authors:  W F Hendry
Journal:  J R Soc Med       Date:  1995-10       Impact factor: 5.344

3.  Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP).

Authors:  Min Chul Cho; Seung Beom Ha; Seung-June Oh; Soo Woong Kim; Jae-Seung Paick
Journal:  World J Urol       Date:  2014-11-07       Impact factor: 4.226

4.  Is transurethral resection of the prostate safe and effective in the over 80-year-old?

Authors:  R D Brierly; A H Mostafid; D Kontothanassis; P J Thomas; M S Fletcher; N W Harrison
Journal:  Ann R Coll Surg Engl       Date:  2001-01       Impact factor: 1.891

5.  [The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures].

Authors:  A Bachmann; O Reich; St Wyler; R Ruszat; R Casella; T Gasser; A Hofstetter; T Sulser
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.